A Study of Impact of Integrating the Lipoprotein Insulin Resistance (LP-IR) Score

Overview

About this study

The purpsoe of this study is to explore the integration of the LP-IR Test into clinical practice.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Currently at least 18 years of age. 
  • Willing to use study kit to provide specimens
  • Be able to participate fully in all aspects of the study. 
  • Have understood and signed study informed consent.

Exclusion Criteria: 

  • Have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 02/24/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Sara Bonnes, M.D., M.S.

Contact us for the latest status

Contact information:

Shawn Fokken CCRP

(507) 293-2740

GIMResearchStudies@mayo.edu

More information

Publications

Publications are currently not available